Xuehong T. Zhang

Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

AKT inhibitor capivasertib reverses EVI1-driven resistance to venetoclax in acute myeloid leukaemia.

AKT inhibitor capivasertib reverses EVI1-driven resistance to venetoclax in acute myeloid leukaemia.

Journal: British journal of haematology

Published: January 21, 2026

The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations.

The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations.

Journal: Annals of hematology

Published: December 24, 2025

Integrated RNA-seq and RT-qPCR Workflow Identifies Non-IGH Fusion Transcripts as Individualized Molecular Markers for Monitoring Multiple Myeloma.

Integrated RNA-seq and RT-qPCR Workflow Identifies Non-IGH Fusion Transcripts as Individualized Molecular Markers for Monitoring Multiple Myeloma.

Journal: Biomedicines

Published: December 24, 2025

Identification of GSE1 as a PAX5 fusion partner and characterization of PAX5 fusion signature in B-cell acute lymphoblastic leukaemia.

Identification of GSE1 as a PAX5 fusion partner and characterization of PAX5 fusion signature in B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: November 14, 2025

Alpha-enolase promotes progression of acute myeloid leukemia via MAPK/ERK signaling pathway.

Alpha-enolase promotes progression of acute myeloid leukemia via MAPK/ERK signaling pathway.

Journal: Blood science (Baltimore, Md.)

Published: February 17, 2025

Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity.

Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity.

Journal: eLife

Published: November 20, 2024

TREML2 enhances sensitivity of acute myeloid leukemia cells to chemotherapy by inhibiting the NF-κB/CXCL10 pathway.

TREML2 enhances sensitivity of acute myeloid leukemia cells to chemotherapy by inhibiting the NF-κB/CXCL10 pathway.

Journal: Blood science (Baltimore, Md.)

Published: November 04, 2024

Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma.

Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma.

Journal: Biology direct

Published: July 28, 2024

CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.

CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.

Journal: Nature communications

Published: April 23, 2024

Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity.

Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity.

Journal: bioRxiv : the preprint server for biology

Published: February 14, 2024

Expression of programmed cell death ligand 1 and clinicopathological and immunological characteristics in fumarate hydratase-deficient renal cell carcinoma

Expression of programmed cell death ligand 1 and clinicopathological and immunological characteristics in fumarate hydratase-deficient renal cell carcinoma

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 28, 2024

Ciwujianoside E inhibits Burkitt lymphoma cell proliferation and invasion by blocking ENO1-plasminogen interaction and TGF-β1 activation.

Ciwujianoside E inhibits Burkitt lymphoma cell proliferation and invasion by blocking ENO1-plasminogen interaction and TGF-β1 activation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 22, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026